Press

MedGenome announces free access to OncoPeptTOPE’TM, its proprietary database of neo-antigens and neo-epitopes

MedGenome recently announced that its proprietary OncoPeptTOPE™ database of neo-antigens and neo-epitopes derived from genetic alterations using TCGA data will be made freely accessible to researchers in the cancer immunotherapy space.

   Healthcare-Industry-Today
   Insurance-Industry-Today
   Science-News-Today
   http://insurance.einnews.com/pr_news/323880415/medgenome-announces-free-access-to-oncopepttope-its-proprietary-database-of-neo-antigens-and-neo-epitopes
   http://science.einnews.com/pr_news/323880415/medgenome-announces-free-access-to-oncopepttope-its-proprietary-database-of-neo-antigens-and-neo-epitopes
   http://health.einnews.com/pr_news/323880415/medgenome-announces-free-access-to-oncopepttope-its-proprietary-database-of-neo-antigens-and-neo-epitopes
Considering Genomic Research?

    Fields marked in * is mandatory to fill
     
     
     

    Company

    Resources

    Research

    Diagnostics

    Contact

    • research@medgenome.com
    • (888) 440-0954
    • MedGenome Inc.
      348 Hatch Drive
      Foster City, CA 94404, USA

      Registered office & Headquarters:
      MedGenome Inc.
      108 West 13th Street Wilmington
      Delaware 19801,
      County of New Castle, USA
    2024 © MedGenome • All Rights Reserved
    Request a Quote